879 related articles for article (PubMed ID: 20624503)
1. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
4. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
[TBL] [Abstract][Full Text] [Related]
5. [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
García-Castro M; Coto E; Reguero JR; Berrazueta JR; Alvarez V; Alonso B; Sainz R; Martín M; Morís C
Rev Esp Cardiol; 2009 Jan; 62(1):48-56. PubMed ID: 19150014
[TBL] [Abstract][Full Text] [Related]
6. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
7. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
9. Mutations profile in Chinese patients with hypertrophic cardiomyopathy.
Song L; Zou Y; Wang J; Wang Z; Zhen Y; Lou K; Zhang Q; Wang X; Wang H; Li J; Hui R
Clin Chim Acta; 2005 Jan; 351(1-2):209-16. PubMed ID: 15563892
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
11. Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.
Brito D; Miltenberger-Miltenyi G; Vale Pereira S; Silva D; Diogo AN; Madeira H
Rev Port Cardiol; 2012 Sep; 31(9):577-87. PubMed ID: 22857948
[TBL] [Abstract][Full Text] [Related]
12. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
[TBL] [Abstract][Full Text] [Related]
13. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
[TBL] [Abstract][Full Text] [Related]
17. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy.
Gruner C; Care M; Siminovitch K; Moravsky G; Wigle ED; Woo A; Rakowski H
Circ Cardiovasc Genet; 2011 Jun; 4(3):288-95. PubMed ID: 21511876
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of a large MYBPC3 rearrangement in a cohort of 100 unrelated patients with hypertrophic cardiomyopathy.
Chanavat V; Seronde MF; Bouvagnet P; Chevalier P; Rousson R; Millat G
Eur J Med Genet; 2012 Mar; 55(3):163-6. PubMed ID: 22314326
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of end-stage hypertrophic cardiomyopathy.
Garcia-Pavia P; Vázquez ME; Segovia J; Salas C; Avellana P; Gómez-Bueno M; Vilches C; Gallardo ME; Garesse R; Molano J; Bornstein B; Alonso-Pulpon L
Eur J Heart Fail; 2011 Nov; 13(11):1193-201. PubMed ID: 21896538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]